Kir6SUR

Kir6SUR refers to the ATP-sensitive potassium (KATP) channel formed by Kir6.x pore-forming subunits and SUR regulatory subunits. The functional channel is an octamer consisting of four Kir6 subunits (Kir6.1 or Kir6.2) and four SUR subunits (SUR1, SUR2A, or SUR2B).

These channels couple cellular energy status to membrane excitability by sensing intracellular ATP and ADP. ATP binding to the Kir6 pore inhibits channel opening, while Mg-ADP binding to the SUR regulatory site promotes opening. When open, potassium efflux hyperpolarizes the cell and reduces voltage-gated calcium entry, modulating secretion or contractility. In pancreatic beta cells, the Kir6.2/SUR1 combination is central to glucose-stimulated insulin secretion. In cardiac and smooth muscle, Kir6.2 or Kir6.1 with SUR2 subtypes regulate vascular tone and myocardial metabolism.

Genetic encoding and tissue distribution vary by subunit composition. KCNJ11 encodes Kir6.2; KCNJ8 encodes Kir6.1. ABCC8 encodes SUR1; ABCC9 encodes SUR2. The subunit combination determines tissue distribution and drug sensitivity: Kir6.2 with SUR1 in pancreatic beta cells; Kir6.2 with SUR2A or Kir6.1 with SUR2B in heart and vascular tissues.

Pharmacology centers on sulfonylurea drugs and KATP channel openers. Sulfonylureas (for example, glibenclamide) bind SUR subunits and close the channel, promoting insulin release. Diazoxide and related openers activate SUR-containing channels to hyperpolarize cells, used in conditions such as hyperinsulinism. Differential isoform sensitivity underlies tissue-specific drug responses.

Mutations in KCNJ11 or ABCC8 can cause neonatal diabetes or congenital hyperinsulinism, underscoring the channel’s key role in metabolic regulation and secretion.